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Spontaneous T cell responses generated against a variety
of solid malignancies are often subverted by immune
evasion mechanisms active in the tumor microenviron-
ment. In contrast, the mechanisms that regulate T cell
activation versus tolerance to hematopoietic malignan-
cies, such as acute myeloid leukemia (AML), have not
been well-characterized. Our recent work in a murine
AML model has demonstrated that following a systemic
introduction of leukemia cells, T cells specific for leuke-
mia-derived antigens underwent abortive proliferation
and were deleted from the host. This deletional toler-
ance in mice with established AML was reversible upon
administration of an agonistic anti-CD40 antibody to
activate host dendritic cells (DCs), and argued that these
cells may play a dominant role in tolerance induction to
AML. Investigation of the DCs populations which
engulfed AML cells in vivo, and which were likely pro-
moting T cell tolerance, led to the critical observation
that AML cells were phagocytosed exclusively by CD11c
+CD8a+ DCs (CD8a+ DCs). CD8a+, but not CD8a-
DCs purified from mice following an intravenous inocu-
lation of AML cells, were able to cross-present leuke-
mia-derived antigens to T cells in vitro, providing
strong evidence that CD8a+ DC generate T cell toler-
ance to AML. Ongoing work utilizing mice deficient in
particular DC subsets is focused on identifying a func-
tional link between CD8a+ DCs and T cell tolerance.
Additionally, the receptors expressed selectively on
CD8a+ DCs which facilitate phagocytosis and cross-pre-
sentation of leukemia derived antigens are under
investigation.
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